This infographic highlights the latest data and insights surrounding the checkpoint-targeting bispecifics landscape, including:
- The current drug landscape, with drugs by disease indication
- Top ICM targets and their combinations
- The current trial landscape, with details on phase progression and trends over the years
- Information on promising assets awaiting approval
To learn more about this infographic, or how Beacon Bispecific can enhance your data needs and provide fast insights, please book a research session below or contact us directly on beacon@hansonwade.com.
Find out more
All data in this infographic is available on Beacon Bispecific
Speak with our team of experts
Our dedicated account and research teams are on hand to showcase how Beacon can help you find the answers to your bispecific-related questions
About Beacon
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
